Vigabatrin versus carbamazepine monotherapy for epilepsy-Reference-Cited by-同舟云学术

Vigabatrin versus carbamazepine monotherapy for epilepsy

Published:2015-11-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Xiao Yousheng¹,Gan Lu¹,Wang Jin¹,Luo Man¹,Luo Hongye²

Affiliation:

1. The First Affiliated Hospital, Guangxi Medical University; Department of Neurology; No. 22, Shuang Yong Lu Nanning Guangxi China 530021

2. Guangxi Medical University; Department of Epidemiology & Statistics; No. 22, Shuang Yong Lu Nanning Guangxi China 530021

Publisher

Wiley

Subject

Pharmacology (medical)

Reference46 articles.

1. Vigabatrin versus carbamazepine as first line monotherapy in newly diagnosed patients: a double blind randomized parallel group study;Canger;Bollettino - Lega Italiana Contro L'Epilessia,1997

2. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study;Chadwick;Lancet,1999

3. Vigabatrin (Sabril) as first-line monotherapy in newly diagnosed epilepsy: a double-blind comparison with carbamazepine;Chadwick;Epilepsia,1996

4. Vigabatrin (Sabril) monotherapy and cognitive function in newly diagnosed epilepsy: a double-blind comparison with carbamazepine;Gisselbrecht;Epilepsia,1996

5. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report;Kalviainen;Journal of Child Neurology,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-convulsant Agents: Vigabatrin;NeuroPsychopharmacotherapy;2022

2. Anticonvulsant Agents: Vigabatrin;NeuroPsychopharmacotherapy;2021

3. Cutaneous Adverse Effects of Neurologic Medications;CNS Drugs;2016-02-25